-5%
Injection Manufacturer/Distributor: Square Pharmaceuticals Ltd. Generic Name: Tranexamic Acid 500 mg/5 ml Injection
Haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis that may occur in conditions:
Â
- Prostatectomy and bladder surgery
- Menorrhagia
- Epistaxis
- Conisation of the cervix
- Management of dental extraction in patients with coagulopathies
- Ulcerative colitis
- Haematuria
- Gastrointestinal haemorrhage
General fibrinolysis as in prostatic and pancreatic cancer, after thoracic and other major surgery, in obstetrical complications such as abruptio placentae and post- partum haemorrhage, in leukaemia and liver diseases and in connection with thrombolytic therapy with streptokinase.
Hereditary angioneurotic oedema.
Â
